Atrium Health Wake Forest Baptist
Medical Center Boulevard
Winston-Salem, NC 27157-1082
Direct phone: (336) 716-2088
Total transplants by cell source
- Marrow: 2
- PBSC: 57
- Cord Blood: 0
- Autologous (PBSC or Marrow): 139
About the center
The adult Stem Cell Transplant and Cellular Therapy program at Atrium Health Wake Forest Baptist is a FACT-accredited program offering autologous and allogeneic transplants. With a mission focused on quality and comprehensive care, the program participates in clinical trials research sponsored by the BMT Clinical Trials Network and the Comprehensive Cancer Center of Wake Forest University. Our experienced staff of dedicated healthcare providers offers both inpatient and outpatient transplants.
This center has been performing allogeneic transplants since 1990 and has been an NMDP/Be The Match transplant center since August 1993.
Adult - Dianna Howard, Sarada Krishmanurthy, Jonathan Lambird, John McKay, Mary Beth Seegars, Rakhee Vaidya
Cord blood transplants performed on
Other programs and services
The Stem Cell Transplant and Cellular Therapy Program of the Atrium Health Wake Forest Baptist Comprehensive Cancer Center is a multidisciplinary adult program offering both autologous and allogeneic transplants. Each patient meets an assigned Transplant Nurse Coordinator at the time of consultation to help navigate the transplant journey. Comprehensive, personalized care is accomplished through our dedicated team of transplant physicians, Advanced Practice Providers (APPs), social workers, nutritionists, clinical practice pharmacists, recreational therapists and transplant-specific RNs. Discounted housing is available through the SECU Family house. A bi-monthly transplant orientation class is offered along with financial counseling and the support of a dedicated Cancer Patient Support Program.
Overall center survival
Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center.
The survival information we have for this center includes ONLY:
- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2017, 2018, 2019, and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 94 patients.
The actual 1-year survival of these patients is 70.1%.
Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 63.3% and 80.8%.
For help with understanding these statistics, please see Understanding Transplant Outcomes.
For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.
Transplants reported (From January 1, 2019 to December 31st, 2020 as reported by the centers)
|Both marrow & PBSC
Transplants by disease
Number of transplants by age reported from January 1, 2019 to December 31st, 2020 (includes marrow, PBSC and cord blood)
Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants for this disease can be found:
Transplant center resources
Transplant center coordinator:
If you have questions about costs and financial services at this center, please call the transplant center's direct phone number.
Be The Match patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
Inside the United States: 1 (888) 999-6743
Outside the United States: 1 (763) 406-3410.
(Long distance or international charges may apply.)